These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6131728)

  • 1. Somatostatin-28 is an hormonally active peptide secreted into hypophysial portal vessel blood.
    Millar RP; Sheward WJ; Wegener I; Fink G
    Brain Res; 1983 Feb; 260(2):334-7. PubMed ID: 6131728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactive somatostatin in rat hypophysial portal blood.
    Gillioz P; Giraud P; Conte-Devolx B; Jaquet P; Codaccioni JL; Oliver C
    Endocrinology; 1979 May; 104(5):1407-10. PubMed ID: 436785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intraventricular injection of neurotensin and other various bioactive peptides on plasma immunoreactive somatostatin levels in rat hypophysial portal blood.
    Abe H; Chihara K; Chiba T; Matsukura S; Fujita T
    Endocrinology; 1981 May; 108(5):1939-43. PubMed ID: 6163624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of immunoreactive somatostatin release into hypophysial portal blood by electrical stimulation of the preoptic area in the rat.
    Chihara K; Arimura A; Kubli-Garfias C; Schally AV
    Endocrinology; 1979 Dec; 105(6):1416-8. PubMed ID: 499080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple forms of somatostatin-like immunoreactivity in the hypothalamus and amygdala of the rat: selective localization of somatostatin-28 in the median eminence.
    Pierotti AR; Harmar AJ
    J Endocrinol; 1985 Jun; 105(3):383-9. PubMed ID: 2860197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-28(1-12)-like immunoreactive substance is secreted into hypophysial portal vessel blood in the rat.
    Sheward WJ; Benoit R; Fink G
    Neuroendocrinology; 1984 Jan; 38(1):88-90. PubMed ID: 6694786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy.
    Plotsky PM; Sawchenko PE
    Endocrinology; 1987 Apr; 120(4):1361-9. PubMed ID: 3030697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Many peptides that are present in the external zone of the median eminence are not secreted into the hypophysial portal blood of sheep.
    Clarke I; Jessop D; Millar R; Morris M; Bloom S; Lightman S; Coen CW; Lew R; Smith I
    Neuroendocrinology; 1993 May; 57(5):765-75. PubMed ID: 7692337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine in plasma of lateral and medial hypophysial portal vessels: evidence for regional variation in the release of hypothalamic dopamine into hypophysial portal blood.
    Reymond MJ; Speciale SG; Porter JC
    Endocrinology; 1983 Jun; 112(6):1958-63. PubMed ID: 6406205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked changes of arginine vasopressin, oxytocin, and corticotropin-releasing hormone in hypophysial portal plasma after pituitary stalk damage in the rat.
    Makara GB; Sutton S; Otto S; Plotsky PM
    Endocrinology; 1995 May; 136(5):1864-8. PubMed ID: 7720631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracerebroventricular administration of growth hormone-releasing factor and corticotropin-releasing factor on somatostatin secretion into rat hypophysial portal blood.
    Mitsugi N; Arita J; Kimura F
    Neuroendocrinology; 1990 Jan; 51(1):93-6. PubMed ID: 1968234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoreactive somatostatin in rat hypophysial portal blood (author's transl)].
    Gillioz P; Giraud P; Conte-Devolx B; Jaquet P; Codaccioni JL; Oliver C
    Ann Endocrinol (Paris); 1979; 40(4):435-6. PubMed ID: 518025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricularly injected growth hormone stimulates somatostatin release into rat hypophysial portal blood.
    Chihara K; Minamitani N; Kaji H; Arimura A; Fujita T
    Endocrinology; 1981 Dec; 109(6):2279-81. PubMed ID: 6118262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation by bombesin of immunoreactive somatostatin release into rat hypophysial portal blood.
    Abe H; Chihara K; Minamitani N; Iwasaki J; Chiba T; Matsukura S; Fujita T
    Endocrinology; 1981 Jul; 109(1):229-34. PubMed ID: 6113130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic secretion of somatostatin and growth hormone-releasing factor into the hypophysial-portal circulation is reduced in streptozotocin diabetic male rats.
    Plotsky PM
    Neuroendocrinology; 1991 May; 53(5):433-8. PubMed ID: 1678493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
    Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased angiotensin-(1-7) in hypophysial-portal plasma of conscious sheep.
    Lawrence AC; Clark IJ; Campbell DJ
    Neuroendocrinology; 1992 Jan; 55(1):105-14. PubMed ID: 1608505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochemical demonstration of somatostatin 28-(1-14)-like immunoreactivity in the rat hypothalamus and gastro-entero-pancreatic endocrine system.
    Iwanaga T; Ito S; Yamada Y; Fujita T
    Endocrinology; 1983 Nov; 113(5):1839-44. PubMed ID: 6138248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural autoradiographic localization of somatostatin-28 in the rat pituitary gland.
    Morel G; Leroux P; Pelletier G
    Endocrinology; 1985 Apr; 116(4):1615-20. PubMed ID: 2857643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlative changes of the gonadotropin-releasing hormone and gonadotropin-releasing-hormone-associated peptide immunoreactivities in the pituitary portal plasma in female rats.
    Sarkar DK; Mitsugi N
    Neuroendocrinology; 1990 Jul; 52(1):15-21. PubMed ID: 2118605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.